WASHINGTON — Francis Collins’ 2022 hasn’t exactly gone according to plan.
The mustachioed, Harley-riding geneticist had looked forward to some respite after serving 12 years as director of the National Institutes of Health. Instead, Collins is more involved than ever in federal science policy. Since February, he’s served as President Biden’s interim science adviser — a position made vacant by Eric Lander’s resignation amid a workplace-abuse scandal.
Since arriving at the White House, Collins has taken over major portions of Lander’s portfolio: namely, standing up the new high-stakes research agency known as ARPA-H; helping to oversee the recently revived Cancer Moonshot, and recruiting the next generation of U.S. scientific leaders.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect